Search clinical trials for: progression free survival (PFS)

Total 11881 results

M.D. Anderson Cancer Center
Celgene

Completed

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Melanoma

United States
Fudan University

Unknown

Bevacizumab Combined With Gefitinib in the Treatment of Advanced NSCLC

PFS

China
Fudan University

Unknown

Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell

PFS

China
Qingdao Central Hospital

Recruiting

Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC

PFS | OS

China
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Safety and Efficacy of Oral Etoposide Combined With Antirotinib and Envollizumab in Elderly Patients With Lung Cancer

Progression Free Survival(PFS)
Laibin People's Hospital

Completed

A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer

The Primary Study Metric is Progression-free Survival (PFS)
Chinese PLA General Hospital
Gansu Provincial Maternity and Child-Care Hospital

Unknown

Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Poorly Healed Wounds of Postoperative Incision

MSCs-PFs in Treating Poorly Healed Wounds of Postoperative Incision
Fudan University

Unknown

Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer

Advanced Gastric Cancer

China
Fudan University

Unknown

Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC

Non Small Cell Lung Cancer

China
Mingzhi Zhang
Zhengzhou University

Completed

Treatment of Peripheral T-cell Lymphoma

Peripheral T-cell Lymphoma

China
Fudan University

Completed

ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC

Non Small Cell Lung Cancer

China
Qian Chu

Completed

A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)

NSCLC

China
Sun Yat-sen University

Unknown

Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer (SYSGO-003)

Quality of Life | PFS | OS

China
The Affiliated Hospital of Qingdao University

Completed

Study for Patients With Lung Metastatic Advanced Gastric Cancer and NSCLC Treated With Apatinib

Lung Cancer | Gastric Cancer Metastatic to Lung
Janssen Research & Development, LLC

Completed

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Breast Cancer | Neoplasm Metastasis

United States, Poland, Ukraine, Taiwan, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Russian Federation, South Africa, Hong Kong, Chile, Brazil, Philippines, Ecuador, Macedonia, The Former Yugoslav Republic... and more
University of Warmia and Mazury

Recruiting

PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment

Neuroendocrine Tumors

Poland
Zhengzhou University

Completed

Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma | Relapsed and Refractory

China
University Hospital Schleswig-Holstein

Recruiting

Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer (OLIGOMA)

Metastatic Breast Cancer

Germany
Peking University People's Hospital
Peking University; Northwestern University; University of Chicago

Unknown

Epigenetic Biomarker for Osteosarcoma

Histologic Response (Tumor Necrosis Rate) | Objective Response Rate for Neoadjuvant Chemotherapy, ORR | Progression-free Survival, PFS | Overall Survival, OS

China
Daping Hospital and the Research Institute of Surgery...

Completed

Combination of Metformin With Gefitinib to Treat NSCLC (CGMT)

NSCLC | Advanced Cancer | EGFR Gene Amplification | Stage IV NSCLC | Stage IIIB NSCLC

China
Peking University

Unknown

Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients

Neuroendocrine Tumors

China
AstraZeneca

Active, not recruiting

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) (MYSTIC)

Non-Small-Cell Lung Carcinoma NSCLC

United States, Belgium, Spain, Canada, Taiwan, Thailand, Vietnam, France, Germany, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, Netherlands, Australia, Switzerland
Hoffmann-La Roche

Completed

Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population

Carcinoma, Non-Small-Cell Lung

China
Peking University

Unknown

Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Enrolling by invitation

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

Diffuse Large B Cell Lymphoma

China
Mingzhi Zhang

Unknown

A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma

China
Mingzhi Zhang

Recruiting

Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma

China
Peking University

Unknown

Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
American University of Beirut Medical Center
Bristol-Myers Squibb

Terminated

A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma

Cholangiocarcinoma

Lebanon, Belgium, Luxembourg
Hangzhou YuYuan Bioscience Technology Co., Ltd.
LG Chem

Completed

Randomized Controlled Study of Comparing Follitrope Versus Gonal-f in Chinese Infertility Women.

Infertility, Female

China
Fuda Cancer Hospital, Guangzhou

Completed

Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Progress Free Survival (PFS) and Overall Survival (OS)

China
Universiteit Antwerpen

Unknown

Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer

Colorectal Cancer

Belgium
Nationwide Children's Hospital

Completed

The Evaluation of a Novel Treatment Algorithm for Patients With Patellofemoral Syndrome (PFSAlgorithm)

Patellofemoral Syndrome

United States
Alexion Pharmaceuticals, Inc.
Parexel

Recruiting

A Study of Subcutaneous Gefurulimab Using Prefilled Syringe Versus Autoinjector in Healthy Adult Participants

Healthy Adult Participants

Canada, United Kingdom
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation (AGIR)

Recurrent IDH1/2 Mutated Glioma

France
AstraZeneca

Active, not recruiting

A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients (PACIFIC-5)

Carcinoma, Non-Small-Cell Lung

Poland, Taiwan, India, Mexico, Russian Federation, Turkey, China, Korea, Republic of, Philippines, Hong Kong
Gilead Sciences

Withdrawn

Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer

Triple-negative Breast Cancer
Deutsches Herzzentrum Muenchen

Unknown

Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography (PPS/PFS-OCT)

Coronary Heart Disease

Germany
AstraZeneca
European Network of Gynaecological Oncological Trial Groups (ENGOT)

Completed

A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer. (OReO)

Epithelial Ovarian Cancer

Denmark, France, Germany, Italy, Spain, Poland, Belgium, Canada, United Kingdom, Israel, Norway
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetics, Safety, and Tolerability Study of the Pen and PFS of SB5 in Healthy Subjects

Healthy

Belgium, New Zealand
University of Iowa

Completed

A Study to Test Lung Function After Radiation Therapy (PFS)

Lung Neoplasms | Neoplasm Metastasis

United States
Mingzhi Zhang
Zhengzhou University

Unknown

Treatment of Primary CNS Lymphoma (FVD)

Primary CNS Lymphoma (PCNSL)

China
Pfizer

Terminated

A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device

Healthy Volunteers

Belgium
Peking University

Terminated

Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Peking University

Unknown

Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor

Neuroendocrine Tumors

China
Neurostream Technologies G.P.

Completed

Pilot Study Assessing the Feasibility of Treating Foot Drop With the Neurostep™ System.

Stroke | Craniocerebral Trauma

United Kingdom, Canada, India
Qingdao Central Hospital

Recruiting

Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer

PFS

China
University Hospital, Basel, Switzerland

Recruiting

Circulating Tumor Cells (CTC) in Cancer

Cancer

Switzerland
Daping Hospital and the Research Institute of Surgery...

Not yet recruiting

Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib

NSCLC | Advanced Cancer | Stage IV NSCLC | BRAF V600E Mutation | Stage IIIB NSCLC
Peking University

Unknown

Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer

Colorectal Cancer

China

3

Subscribe